Biophysical characterization of the fusogenic region of HCV envelope glycoprotein E1

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 10, 2009, Pages 2183-2193

  Pérez Berná, Ana J ^a   Pabst, Georg ^b   Laggner, Peter ^b   Villalaín, José ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

HCV; HCV E1 glycoprotein; Membrane fusion; Peptide lipid interaction

Indexed keywords

CHOLESTEROL; GLYCOPROTEIN E1; MEMBRANE PHOSPHOLIPID; MEMBRANE PROTEIN;

ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; MEMBRANE BINDING; MEMBRANE FUSION; MEMBRANE POTENTIAL; MEMBRANE STABILIZATION; NONHUMAN; PHOSPHOLIPID BILAYER; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LIPID INTERACTION;

BIOPHYSICS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LIPID BILAYERS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE FUSION; MEMBRANES; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 70349498835     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.08.002     Document Type: Article

References (71)

1. Chen S.L., and Morgan T.R. The natural history of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 3 (2006) 47-52
2. Penin F., Dubuisson J., Rey F.A., Moradpour D., and Pawlotsky J.M. Structural biology of hepatitis C virus. Hepatology 39 (2004) 5-19
3. Tan S.L., Pause A., Shi Y., and Sonenberg N. Hepatitis C therapeutics: current status and emerging strategies. Nat. Rev., Drug Discov. 1 (2002) 867-881
4. Wong V.K., Cheong-Lee C., Ford J.A., and Yoshida E.M. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy. World J. Gastroenterol. 11 (2005) 5392-5393
5. Reed K.E., and Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242 (2000) 55-84
6. Vauloup-Fellous C., Pene V., Garaud-Aunis J., Harper F., Bardin S., Suire Y., Pichard E., Schmitt A., Sogni P., Pierron G., Briand P., and Rosenberg A.R. Signal peptide peptidase-catalyzed cleavage of hepatitis C virus core protein is dispensable for virus budding but destabilizes the viral capsid. J. Biol. Chem. 281 (2006) 27679-27692
7. Lavillette D., Bartosch B., Nourrisson D., Verney G., Cosset F.L., Penin F., and Pecheur E.I. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J. Biol. Chem. 281 (2006) 3909-3917
8. Pozzetto B., Bourlet T., Grattard F., and Bonnevial L. Structure, genomic organization, replication and variability of hepatitis C virus. Nephrol. Dial. Transplant. 11 Suppl 4 (1996) 2-5
9. Bartosch B., Dubuisson J., and Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197 (2003) 633-642
10. Op De Beeck A., Montserret R., Duvet S., Cocquerel L., Cacan R., Barberot B., Le Maire M., Penin F., and Dubuisson J. The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. J. Biol. Chem. 275 (2000) 31428-31437
11. Lavillette D., Pecheur E.I., Donot P., Fresquet J., Molle J., Corbau R., Dreux M., Penin F., and Cosset F.L. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 81 (2007) 8752-8765
12. Garry R.F., and Dash S. Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. Virology 307 (2003) 255-265
13. Jardetzky T.S., and Lamb R.A. Virology: a class act. Nature 427 (2004) 307-308
14. Bartosch B., and Cosset F.L. Cell entry of hepatitis C virus. Virology 348 (2006) 1-12
15. Yagnik A.T., Lahm A., Meola A., Roccasecca R.M., Ercole B.B., Nicosia A., and Tramontano A. A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40 (2000) 355-366
16. Roccasecca R., Ansuini H., Vitelli A., Meola A., Scarselli E., Acali S., Pezzanera M., Ercole B.B., McKeating J., Yagnik A., Lahm A., Tramontano A., Cortese R., and Nicosia A. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2. J. Virol. 77 (2003) 1856-1867
17. Perez-Berna A.J., Guillen J., Moreno M.R., Bernabeu A., Pabst G., Laggner P., and Villalain J. Identification of the membrane-active regions of hepatitis C virus p7 protein: biophysical characterization of the loop region. J. Biol. Chem. 283 (2008) 8089-8101
18. Perez-Berna A.J., Veiga A.S., Castanho M.A., and Villalain J. Hepatitis C virus core protein binding to lipid membranes: the role of domains 1 and 2. J. Viral Hepatitis 15 (2008) 346-356
19. Perez-Berna A.J., Moreno M.R., Guillen J., Bernabeu A., and Villalain J. The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins. Biochemistry 45 (2006) 3755-3768
20. Earp L.J., Delos S.E., Park H.E., and White J.M. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285 (2005) 25-66
21. Peisajovich S.G., and Shai Y. Viral fusion proteins: multiple regions contribute to membrane fusion. Biochim. Biophys. Acta 1614 (2003) 122-129
22. Epand R.M. Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta 1614 (2003) 116-121
23. Zhang Y.P., Lewis R.N., Hodges R.S., and McElhaney R.N. FTIR spectroscopic studies of the conformation and amide hydrogen exchange of a peptide model of the hydrophobic transmembrane alpha-helices of membrane proteins. Biochemistry 31 (1992) 11572-11578
24. Mayer L.D., Hope M.J., and Cullis P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 858 (1986) 161-168
25. Böttcher C.S.F., Van Gent C.M., and Fries C. A rapid and sensitive sub-micro phosphorus determination. Anal. Chim. Acta 1061 (1961) 203-204
26. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6 (1967) 1948-1954
27. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
28. Moreno M.R., Guillen J., Perez-Berna A.J., Amoros D., Gomez A.I., Bernabeu A., and Villalain J. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes. Biochemistry 46 (2007) 10572-10584
29. Sainz Jr. B., Rausch J.M., Gallaher W.R., Garry R.F., and Wimley W.C. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J. Virol. 79 (2005) 7195-7206
30. Eftink M.R., and Ghiron C.A. Exposure of tryptophanyl residues and protein dynamics. Biochemistry 16 (1977) 5546-5551
31. Perez-Berna A.J., Guillen J., Moreno M.R., Gomez-Sanchez A.I., Pabst G., Laggner P., and Villalain J. Interaction of the most membranotropic region of the HCV E2 envelope glycoprotein with membranes. Biophysical characterization. Biophys. J. 94 12 (2008) 4737-4750
32. Wall J., Ayoub F., and O'Shea P. Interactions of macromolecules with the mammalian cell surface. J. Cell Sci. 108 Pt 7 (1995) 2673-2682
33. Gross E., Bedlack Jr. R.S., and Loew L.M. Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys. J. 67 (1994) 208-216
34. Vitha M.F., and Clarke R.J. Comparison of excitation and emission ratiometric fluorescence methods for quantifying the membrane dipole potential. Biochim. Biophys. Acta 1768 (2007) 107-114
35. Veiga A.S., Santos N.C., Loura L.M., Fedorov A., and Castanho M.A. HIV fusion inhibitor peptide T-1249 is able to insert or adsorb to lipidic bilayers. Putative correlation with improved efficiency. J. Am. Chem. Soc. 126 (2004) 14758-14763
36. Laggner P. X-ray diffraction on biomembranes with emphasis on lipid moiety. Subcell. Biochem. 23 (1994) 451-491
37. Pabst G. Global properties of biomimetic membranes: perspectives on molecular features. Biophys. Rev. Lett. 1 (2006) 57-84
38. Contreras L.M., Aranda F.J., Gavilanes F., Gonzalez-Ros J.M., and Villalain J. Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism. Biochemistry 40 (2001) 3196-3207
39. Engelman D.M., Steitz T.A., and Goldman A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. Biophys. Chem. 15 (1986) 321-353
40. Wimley W.C., and White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3 (1996) 842-848
41. White S.H., and Wimley W.C. Hydrophobic interactions of peptides with membrane interfaces. Biochim. Biophys. Acta 1376 (1998) 339-352
42. Moreno M.R., Giudici M., and Villalain J. The membranotropic regions of the endo and ecto domains of HIV gp41 envelope glycoprotein. Biochim. Biophys. Acta 1758 (2006) 111-123
43. Drummer H.E., and Poumbourios P. Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. J. Biol. Chem. 279 (2004) 30066-30072
44. Pascual R., Contreras M., Fedorov A., Prieto M., and Villalain J. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior. Biochemistry 44 (2005) 14275-14288
45. Nieva J.L., Goni F.M., and Alonso A. Liposome fusion catalytically induced by phospholipase C. Biochemistry 28 (1989) 7364-7367
46. Santos N.C., Prieto M., and Castanho M.A. Interaction of the major epitope region of HIV protein gp41 with membrane model systems. A fluorescence spectroscopy study. Biochemistry 37 (1998) 8674-8682
47. Pascual R., Moreno M.R., and Villalain J. A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism. J. Virol. 79 (2005) 5142-5152
48. Wall J., Golding C.A., Van Veen M., and O'Shea P. The use of fluoresceinphosphatidylethanolamine (FPE) as a real-time probe for peptide-membrane interactions. Mol. Membr. Biol. 12 (1995) 183-192
49. Fuller N., Benatti C.R., and Rand R.P. Curvature and bending constants for phosphatidylserine-containing membranes. Biophys. J. 85 (2003) 1667-1674
50. Chattopadhyay S., Sun P., Wang P., Abonyo B., Cross N.L., and Liu L. Fusion of lamellar body with plasma membrane is driven by the dual action of annexin II tetramer and arachidonic acid. J. Biol. Chem. 278 (2003) 39675-39683
51. Meers P., Ali S., Erukulla R., and Janoff A.S. Novel inner monolayer fusion assays reveal differential monolayer mixing associated with cation-dependent membrane fusion. Biochim. Biophys. Acta 1467 (2000) 227-243
52. Ahn A., Gibbons D.L., and Kielian M. The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J. Virol. 76 (2002) 3267-3275
53. Lavillette D., Tarr A.W., Voisset C., Donot P., Bartosch B., Bain C., Patel A.H., Dubuisson J., Ball J.K., and Cosset F.L. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41 (2005) 265-274
54. de Almeida R.F., Fedorov A., and Prieto M. Sphingomyelin/phosphatidylcholine/cholesterol phase diagram: boundaries and composition of lipid rafts. Biophys. J. 85 (2003) 2406-2416
55. Killian J.A., and de Kruijff B. The influence of proteins and peptides on the phase properties of lipids. Chem. Phys. Lipids 40 (1986) 259-284
56. Kielian M., and Rey F.A. Virus membrane-fusion proteins: more than one way to make a hairpin. Nat. Rev., Microbiol. 4 (2006) 67-76
57. Schibli D.J., and Weissenhorn W. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol. Membr. Biol. 21 (2004) 361-371
58. Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A., Rawat S.S., Puri A., Durell S., and Blumenthal R. The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614 (2003) 36-50
59. Kielian M., and Class I.I. Virus membrane fusion proteins. Virology 344 (2006) 38-47
60. Ciczora Y., Callens N., Penin F., Pecheur E.I., and Dubuisson J. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. J. Virol. 81 (2007) 2372-2381
61. Ciczora Y., Callens N., Montpellier C., Bartosch B., Cosset F.L., Op de Beeck A., and Dubuisson J. Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. J. Gen. Virol. 86 (2005) 2793-2798
62. Keck Z.Y., Op De Beeck A., Hadlock K.G., Xia J., Li T.K., Dubuisson J., and Foung S.K. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions. J. Virol. 78 (2004) 9224-9232
63. Brazzoli M., Helenius A., Foung S.K., Houghton M., Abrignani S., and Merola M. Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. Virology 332 (2005) 438-453
64. Pabst G., Danner S., Podgornik R., and Katsaras J. Entropy-driven softening of fluid lipid bilayers by alamethicin. Langmuir 23 (2007) 11705-11711
65. Pabst G., Grage S.L., Danner-Pongratz S., Jing W., Ulrich A.S., Watts A., Lohner K., and Hickel A. Membrane thickening by the antimicrobial peptide PGLa. Biophys. J. 95 (2008) 5779-5788
66. Huang H.W. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta 1758 (2006) 1292-1302
67. Tristram-Nagle S., and Nagle J.F. HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates. Biophys. J. 93 (2007) 2048-2055
68. Pabst G., Katsaras J., and Raghunathan V.A. Enhancement of steric repulsion with temperature in oriented lipid multilayers. Phys. Rev. Lett. 88 (2002) 128101
69. Pozo-Navas B., Raghunathan V.A., Katsaras J., Rappolt M., Lohner K., and Pabst G. Discontinuous unbinding of lipid multibilayers. Phys. Rev. Lett. 91 (2003) 028101
70. Dimitrov A.S., Xiao X., Dimitrov D.S., and Blumenthal R. Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes. J. Biol. Chem. 276 (2001) 30335-30341
71. Guillen J., Perez-Berna A.J., Moreno M.R., and Villalain J. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism. J. Virol. 79 (2005) 1743-1752